liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Getting value today and incentivising for the future: Pharmaceutical development and healthcare policies
Linköping University, Department of Medical and Health Sciences, Division of Health Care Analysis. Linköping University, Faculty of Medicine and Health Sciences. Department of Health Economics, AstraZeneca Nordic, Södertälje, Sweden .
Department of Health Economics, AstraZeneca Nordic, Södertälje, Sweden.
2017 (English)In: Nordic Journal of Health Economics, ISSN 1892-9729, E-ISSN 1892-9710, Vol. 5, no 1, p. 77-96Article, review/survey (Refereed) Published
Abstract [en]

To manage the challenge of limited healthcare resources and unlimited demand for healthcare, decision makers utilise a variety of demand side policies, such as health technology appraisals and international reference pricing to regulate price and utilisation. By controlling price and utilisation demand side policies determine the earnings potential, and hence the incentives to invest in research and development (R&D) of new technologies. However, the impact of demand side policies on R&D incentives is seldom formally assessed. Based on the key assumption that intellectual property rights, i.e. patents, and expected rent are key drivers of pharmaceutical R&D, this work outlines a framework illustrating the link between demand side policies and pharmaceutical R&D incentives. By analysing how policies impact expected rent and consumer surplus, the framework is used to understand how commonly used demand side policies (including timing and length of reimbursement process, international reference pricing, parallel trade, and sequential adoption into clinical practice) may influence R&D incentives. The analysis demonstrates that delayed reimbursement decisions as well as sequential adoption into clinical practise may in fact reduce both expected rent and consumer surplus. It is also demonstrated how international reference pricing is likely to increase consumer surplus at the expense of lower rent and thus lower R&D incentives. Although this work illustrates the importance of considering how demand side policies may impact long-term R&D incentives, it is important to note that the purpose has not been to prescribe which demand side policies should be utilised or how. Rather, the main contribution is to illustrate the need for a structured approach to the analysis of the complex, and at times highly politicised question of how demand side policies ultimately influence population health, both in the short and in the long term.

Place, publisher, year, edition, pages
University of Oslo , 2017. Vol. 5, no 1, p. 77-96
Keywords [en]
pharmaceutical market, pharmaceutical regulation, R&D incentives, intellectual property rights
National Category
Health Care Service and Management, Health Policy and Services and Health Economy
Identifiers
URN: urn:nbn:se:liu:diva-154061DOI: 10.5617/njhe.888OAI: oai:DiVA.org:liu-154061DiVA, id: diva2:1282483
Available from: 2019-01-24 Created: 2019-01-24 Last updated: 2019-03-07

Open Access in DiVA

fulltext(1214 kB)57 downloads
File information
File name FULLTEXT01.pdfFile size 1214 kBChecksum SHA-512
fa1737f3cef44a637e4b025ba934541696fd7eb01a0a76dd9a7266ba5c0196bad36fca9b22be7f3cdd45d9e51c89a3e81267ef592bdca847d836d9073536f3a0
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Johannesen, KasperHenriksson, Martin

Search in DiVA

By author/editor
Johannesen, KasperHenriksson, Martin
By organisation
Division of Health Care AnalysisFaculty of Medicine and Health Sciences
In the same journal
Nordic Journal of Health Economics
Health Care Service and Management, Health Policy and Services and Health Economy

Search outside of DiVA

GoogleGoogle Scholar
Total: 57 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 51 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf